MX2016005613A - Sistemas de cuantificacion de patogenesis y metodos de tratamiento para el enverdecimiento de los citricos. - Google Patents

Sistemas de cuantificacion de patogenesis y metodos de tratamiento para el enverdecimiento de los citricos.

Info

Publication number
MX2016005613A
MX2016005613A MX2016005613A MX2016005613A MX2016005613A MX 2016005613 A MX2016005613 A MX 2016005613A MX 2016005613 A MX2016005613 A MX 2016005613A MX 2016005613 A MX2016005613 A MX 2016005613A MX 2016005613 A MX2016005613 A MX 2016005613A
Authority
MX
Mexico
Prior art keywords
citrus greening
pathogenesis
blight
treatment methods
pathogen
Prior art date
Application number
MX2016005613A
Other languages
English (en)
Other versions
MX367192B (es
Inventor
M Lloyd Robert Jr
Original Assignee
Green Life Biotech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Life Biotech Llc filed Critical Green Life Biotech Llc
Publication of MX2016005613A publication Critical patent/MX2016005613A/es
Publication of MX367192B publication Critical patent/MX367192B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere a un modelo de patogénesis novedoso, método o kit para detectar la patogénesis en un sujeto. En particular, la invención proporciona un índice patógeno obtenido de una relación de la cantidad de dianas de patógeno dual con respecto a la cantidad de medidas cuantitativas de hospedador. El índice patógeno se usa en el diagnóstico, el pronóstico y/o la estrategia de tratamiento de cualquier enfermedad, que incluye las enfermedades de enverdecimiento de los cítricos (HLB). También se proporcionan herramientas de investigación y métodos para el análisis de fármacos para el tratamiento o la prevención de enfermedades de enverdecimiento de los cítricos, así como métodos de tratamiento o prevención de enfermedades de enverdecimiento de los cítricos.
MX2016005613A 2013-10-30 2014-10-30 Sistemas de cuantificacion de patogenesis y metodos de tratamiento para el enverdecimiento de los citricos. MX367192B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361897626P 2013-10-30 2013-10-30
PCT/US2014/063181 WO2015066341A2 (en) 2013-10-30 2014-10-30 Pathogenesis quantification systems and treatment methods for citrus greening blight

Publications (2)

Publication Number Publication Date
MX2016005613A true MX2016005613A (es) 2016-12-20
MX367192B MX367192B (es) 2019-08-08

Family

ID=53005380

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016005613A MX367192B (es) 2013-10-30 2014-10-30 Sistemas de cuantificacion de patogenesis y metodos de tratamiento para el enverdecimiento de los citricos.

Country Status (6)

Country Link
US (2) US10351918B2 (es)
EP (1) EP3063272A2 (es)
JP (1) JP2016538882A (es)
CN (1) CN105722977A (es)
MX (1) MX367192B (es)
WO (1) WO2015066341A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX367192B (es) 2013-10-30 2019-08-08 Green Life Biotech Llc Sistemas de cuantificacion de patogenesis y metodos de tratamiento para el enverdecimiento de los citricos.
US10501814B2 (en) * 2015-12-28 2019-12-10 PathogenDX Inc Microarray based multiplex pathogen analysis and uses thereof
US10612075B2 (en) * 2015-12-28 2020-04-07 PathogenDX Inc Microarray based multiplex pathogen analysis and uses thereof
US10513745B2 (en) * 2015-12-28 2019-12-24 PathogenDX Inc Microarray based multiplex pathogen analysis and uses thereof
US20190137476A1 (en) * 2016-03-25 2019-05-09 The Regents Of The University Of California Detecting huanglongbing (hlb) in citrus plants by analyzing changes in emitted volatile organic compounds
DE102016207147A1 (de) * 2016-04-27 2017-11-02 Nordkorn Saaten Gmbh Verfahren zum Nachweis von biologisch aktiven Pflanzenpathogenen
CN106929584A (zh) * 2017-03-30 2017-07-07 上海市农业科学院 一种检测Camv35S启动子的RPA引物、试剂盒及检测方法
WO2020102537A1 (en) * 2018-11-14 2020-05-22 Washington State University Host-free 'candidatus liberibacter asiaticus' culture
CN114829882B (zh) 2019-11-05 2023-02-28 阿比尔技术公司 植物产品中感染的预测
CN116018144A (zh) * 2020-06-15 2023-04-25 玛希敦大学 一种含有源自Astraeus Asiaticus的治疗剂的抗病毒药物组合物
CN111944919B (zh) * 2020-07-31 2023-05-26 广东省农业科学院果树研究所 一种可以在田间、常温操作的香蕉枯萎病菌热带4号小种可视化检测技术体系
CN112280879A (zh) * 2020-11-17 2021-01-29 广东省农业科学院植物保护研究所 一种快速检测柑橘黄龙病亚洲种的rpa引物、试剂盒及其检测方法与应用

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4469863A (en) 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US5235033A (en) 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
DE3529478A1 (de) 1985-08-16 1987-02-19 Boehringer Mannheim Gmbh 7-desaza-2'desoxyguanosin-nukleotide, verfahren zu deren herstellung und deren verwendung zur nukleinsaeure-sequenzierung
US5216141A (en) 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
US6642245B1 (en) 1990-02-01 2003-11-04 Emory University Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
CA2039517C (en) 1990-04-03 2006-11-07 David Segev Dna probe signal amplification
US6787338B2 (en) 1990-06-04 2004-09-07 The University Of Utah Method for rapid thermal cycling of biological samples
US5386023A (en) 1990-07-27 1995-01-31 Isis Pharmaceuticals Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
US5602240A (en) 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
US5484908A (en) 1991-11-26 1996-01-16 Gilead Sciences, Inc. Oligonucleotides containing 5-propynyl pyrimidines
DE637965T1 (de) 1991-11-26 1995-12-14 Gilead Sciences Inc Gesteigerte bildung von triple- und doppelhelices aus oligomeren mit modifizierten pyrimidinen.
TW393513B (en) 1991-11-26 2000-06-11 Isis Pharmaceuticals Inc Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
US5644048A (en) 1992-01-10 1997-07-01 Isis Pharmaceuticals, Inc. Process for preparing phosphorothioate oligonucleotides
JPH09504785A (ja) 1993-09-10 1997-05-13 エモリー、ユニバーシティー 抗ｂ型肝炎ウイルス活性を有するヌクレオシド
US5637684A (en) 1994-02-23 1997-06-10 Isis Pharmaceuticals, Inc. Phosphoramidate and phosphorothioamidate oligomeric compounds
US5972716A (en) 1994-04-29 1999-10-26 The Perkin-Elmer Corporation Fluorescence monitoring device with textured optical tube and method for reducing background fluorescence
US5545527A (en) 1994-07-08 1996-08-13 Visible Genetics Inc. Method for testing for mutations in DNA from a patient sample
US5834189A (en) 1994-07-08 1998-11-10 Visible Genetics Inc. Method for evaluation of polymorphic genetic sequences, and the use thereof in identification of HLA types
US6800452B1 (en) 1994-08-08 2004-10-05 Science Applications International Corporation Automated methods for simultaneously performing a plurality of signal-based assays
DE69638137D1 (de) 1995-09-07 2010-04-15 Univ Georgia Therapeutische azidverbindungen
US6265152B1 (en) 1995-12-22 2001-07-24 Visible Genetics Inc. Method and kit for evaluation of HIV mutations
US6007983A (en) 1995-12-22 1999-12-28 Visible Genetics Inc. Method and kit for evaluation of HIV mutations
US5795722A (en) 1997-03-18 1998-08-18 Visible Genetics Inc. Method and kit for quantitation and nucleic acid sequencing of nucleic acid analytes in a sample
US6180777B1 (en) 1996-01-12 2001-01-30 Bayer Corporation Synthesis of branched nucleic acids
FR2746413B1 (fr) 1996-03-19 1998-04-24 Bio Merieux Detection d'une sequence nucleotidique avec amplification de signal
US6830887B2 (en) 1997-03-18 2004-12-14 Bayer Healthcare Llc Method and kit for quantitation and nucleic acid sequencing of nucleic acid analytes in a sample
DK0866071T3 (da) 1997-03-20 2005-01-17 Hoffmann La Roche Modificerede primere
JP2001514859A (ja) 1997-09-04 2001-09-18 バイエル コーポレイション クエンチ可能な蛍光標識を有するオリゴヌクレオチドプローブおよびその使用方法
DE69933860T2 (de) 1998-02-25 2007-05-31 Emory University 2'-fluoronukleoside
ES2369818T3 (es) 1998-11-09 2011-12-07 Eiken Kagaku Kabushiki Kaisha Procedimiento de síntesis de ácido nucleico.
US7115584B2 (en) 1999-01-22 2006-10-03 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
US7635690B2 (en) 1999-01-22 2009-12-22 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
ATE314488T1 (de) 1999-03-18 2006-01-15 Exiqon As Einstufige probezubereitung und bestimmung von nukleinsäure in biologischen proben
US6734291B2 (en) 1999-03-24 2004-05-11 Exiqon A/S Synthesis of [2.2.1]bicyclo nucleosides
JP4768132B2 (ja) 1999-03-24 2011-09-07 エクシコン エ／エス ［２．２．１］ビシクロヌクレオシドの改良された製法
JP4683811B2 (ja) 2000-05-01 2011-05-18 栄研化学株式会社 核酸合成反応産物の検出方法
EP2031058B1 (en) 2000-09-19 2012-07-18 Eiken Kagaku Kabushiki Kaisha Method of synthesizing polynucleotide
DE60322044D1 (de) 2002-02-21 2008-08-21 Asm Scient Inc Rekombinase-polymerase-amplifikation
US7399590B2 (en) 2002-02-21 2008-07-15 Asm Scientific, Inc. Recombinase polymerase amplification
US7662594B2 (en) 2002-09-20 2010-02-16 New England Biolabs, Inc. Helicase-dependent amplification of RNA
US7282328B2 (en) 2002-09-20 2007-10-16 New England Biolabs, Inc. Helicase dependent amplification of nucleic acids
JP4686189B2 (ja) 2002-10-24 2011-05-18 パラテック ファーマシューティカルズ インコーポレイテッド Ｒｎａを調節するための置換テトラサイクリン化合物の使用方法
ATE407939T1 (de) 2004-06-02 2008-09-15 Asm Scient Inc 2ß-NITROBENZYL-MODIFIZIERTE RIBONUKLEOTIDE
US7629124B2 (en) 2006-06-30 2009-12-08 Canon U.S. Life Sciences, Inc. Real-time PCR in micro-channels
CA2722308C (en) 2008-04-15 2024-02-27 Rfs Pharma, Llc. Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
US9758837B2 (en) * 2011-08-02 2017-09-12 The United States Of America, As Represented By The Secretary Of Agriculture Sensitive and rapid method for Candidatus Liberibacter species detection
MX367192B (es) 2013-10-30 2019-08-08 Green Life Biotech Llc Sistemas de cuantificacion de patogenesis y metodos de tratamiento para el enverdecimiento de los citricos.

Also Published As

Publication number Publication date
CN105722977A (zh) 2016-06-29
WO2015066341A3 (en) 2015-11-12
US10351918B2 (en) 2019-07-16
JP2016538882A (ja) 2016-12-15
US10815537B2 (en) 2020-10-27
MX367192B (es) 2019-08-08
WO2015066341A2 (en) 2015-05-07
US20160319379A1 (en) 2016-11-03
EP3063272A2 (en) 2016-09-07
US20190300971A1 (en) 2019-10-03

Similar Documents

Publication Publication Date Title
MX2016005613A (es) Sistemas de cuantificacion de patogenesis y metodos de tratamiento para el enverdecimiento de los citricos.
WO2014149134A3 (en) Systems and methods to detect rare mutations and copy number variation
WO2014151006A3 (en) Biomarkers and methods of treating pd-1 and pd-l1 related conditions
MX367963B (es) Métodos para detectar mutaciones raras y variación en el número de copias.
WO2012135844A3 (en) Circulating exosomes as diagnostic/prognostic indicators and therapeutic targets of melanoma and other cancers
CA2941917C (en) Methods for the diagnosis and treatment of inflammatory bowel disease
MX2015005015A (es) Inhibidores heteroarilo de pde4.
WO2013008102A3 (en) Methods and compositions for evaluating and/or treating chronic immune diseases
MX2022008523A (es) Compuestos que interactuan con glicanos y metodos de uso.
EA201491339A1 (ru) Замещенные аннеллированные пиримидины и триазины и их применение
EA201490546A1 (ru) Замещенные аннелированные пиримидины и их применение
MX2014011500A (es) Diagnosticos y tratamientos relacionados a inhibidores her3.
MX2015000863A (es) Anticuerpos anti-siglec-15.
EP3394032A4 (en) COMPOUNDS AND METHODS OF TREATMENT, DETECTION AND IDENTIFICATION OF COMPOUNDS FOR THE TREATMENT OF PARASITIC ILLNESSES BY APICOMPLEXA
EP2723866A4 (en) METHOD FOR THE PROGNOSIS AND / OR DIAGNOSIS OF NEURODEEGENERATIVE DISEASES, METHOD FOR IDENTIFYING COMPOUND CANDIDATES AND COMPOUNDS FOR THE TREATMENT OF NEURODEGENATIVE DISEASES
WO2014028862A9 (en) Use of dna in circulating exosomes as a diagnostic marker for metastasic disease
MX2018001831A (es) Biomarcadores para el tratamiento de alopecia areata.
TR201909951T4 (tr) Kanser olduğundan şüphelenilen bir hastanın aflibersept ile tedavisinin sonucunun öngörülmesine yönelik yöntem.
WO2012012278A3 (en) Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex
WO2014197835A3 (en) Methods and compositions for the treatment of cancer
MX2015011359A (es) Inhibidores macrociclicos de cinasa 2 de repeticion rica en leucina (lrrk2).
MX2015012526A (es) Inhibodores macrociclicos de cinasa rip2.
WO2015013508A3 (en) Methods for diagnosing and treating immune disease
CA2888908A1 (en) Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
WO2013052108A3 (en) Methods and compositions for the treatment and diagnosis of ovarian cancer

Legal Events

Date Code Title Description
FG Grant or registration